{"page_content": "MORE INFORMATION \nAmgen\u2019s Commitment to Diversity, Inclusion and Belonging43\n2020 DI&B Data12\n100%\n80%\n60%\n40%\n20% 52 %47%Management level13\n42%Executive level14\nWomen\nin total \nworkforce\n12 Data as of December 2020. To align with U.S. government reporting requirements, data in this \ndocument uses the traditional gender categories of male and female. We deeply respect that \ngender is not binary; reporting in this manner should not represent our position on the issue. \nTotals may not add up to 100% due to rounding or employees who have not reported their \ngender and/or race/ethnicity.\n13 Management:  Senior managers and directors.\n14 Executive level: Executive directors and above.\n15 Other: American Indian/Alaska Native, Native Hawaiian or Pacific Islander, two or more races, \nor not specified.80%\n60%\n40%\n20% 48 %\nEthnic \nminority in \nthe workforce\n(U.S./P .R.)\n42%Management level13\n30%Executive level1480%\n60%\n40%\n20% 48 %\nEthnic \nminority in \nthe workforce\n(U.S./P .R.)\n19%Asian\n4%Other1524%Hispanic/ Latino\n3%Black/\nAfrican \nAmerican100% 100%\nAlthough we do not use our Federal Employer Information \nReport EEO-1 to measure progress, we make our most \nrecent filing publicly available.  For more information \naround the composition of our workforce, please go to our \n2020 Workforce Diversity Report.DIVERSITY, INCLUSION, \nAND BELONGINGINTRODUCTIONRESPONSIBLE \nSOURCINGCOMMUNITY \nINVESTMENTAPPENDIXENVIRONMENTAL\nSUSTAINABILITYGOVERNANCECOVID- 19 \nRESPONSEBUSINESS \nETHICSETHICAL \nRESEARCHACCESS TO \nMEDICINE", "metadata": {"source": "NASDAQ_AMGN_2020.pdf", "page": 42, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}